New Delhi: The mission to prepare vaccines all for prevention of global epidemic coronavirus infection is going on. But in the meantime there is bad news. The first of the vaccines being prepared for the prevention of coronavirus has failed in the trial. These vaccines have failed to win the coronavirus during clinical trials. This has been revealed in the report released by the World Health Organization (WHO) with 'mistake'.

According to media reports, Gilead company prepared an antiviral vaccine for the prevention of coronavirus infection. But this vaccine has proved to be a failure in clinical trials in China. According to the report, the anti-viral vaccine Remdesivir vaccine has failed to prevent coronavirus infection. However, Gilead has reacted to this news saying that the report released by WHO is incomplete. The company claims that more people could not be found in China for clinical trials. This is the reason why the trial has not been completed yet.

Experts related to the case say that most American and European companies have accelerated their trials. The first vaccine is expected in June or July. However, the launch of the vaccine also depends on how quickly they meet the safety standards.

Also Read: 

Employment crisis in America after 90 years, 44 lakh people seeks unemployment allowance

'Pakistan's lockdown is no less than a joke', people still going to mosques

Alia Bhatt finds new friend amidst lockdown

World Bank: Remittance to India are likely to drop by 23 percent